{"id":"W4399480781","doi":"10.1200/jco.2024.42.16_suppl.tps7089","title":"BELLWAVE-010: A phase 3 study of nemtabrutinib plus venetoclax versus venetoclax plus rituximab (VR) in previously treated patients (pts) with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Medicine; Chronic lymphocytic leukemia; Rituximab; Refractory (planetary science); Lymphoma; Bendamustine; Internal medicine; Oncology; Leukemia","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001428608,0.001244675,0.001242895,0.0003669931,0.0003728872,0.001202728,0.001268251,0.001526296,0.01208754],"category_scores_gemma":[0.0009336816,0.0005480662,0.00139321,0.000345943,0.0007751261,0.001118017,0.0004126293,0.004644762,0.002086631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001176279,"about_ca_system_score_gemma":0.001771832,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001409837,"about_ca_topic_score_gemma":0.004767222,"domain_scores_codex":[0.9997134,0.0001261908,0.00001131729,0.00004395712,0.00003321854,0.00007186744],"domain_scores_gemma":[0.9994167,0.00008962626,0.0001339601,0.00002758124,0.00004184904,0.0002904157],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7452636,0.07327083,0.003727168,0.00190254,0.001458187,0.0002420235,0.0002834338,0.002169078,0.02216787,0.0008091182,0.02029491,0.1284114],"study_design_scores_gemma":[0.7193136,0.2651873,0.006399171,0.0001212012,0.0004979031,0.0002961671,0.00008153937,0.001299704,0.001123938,0.0004026006,0.005240943,0.00003586725],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9685977,0.007005144,0.001215218,0.001931885,0.0004422013,0.006527946,0.004964434,0.0005063533,0.008809148],"genre_scores_gemma":[0.9544306,0.006838208,0.003975608,0.00604113,0.0003614849,0.008064955,0.008264874,0.0001177019,0.01190556],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01208754,"threshold_uncertainty_score":0.04043692,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09580237776698809,"score_gpt":0.4350150633324789,"score_spread":0.3392126855654908,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}